Chen X - Search Results

1

MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.

Hou Q, Huang Y, Zhu S, Li P, Chen X, Hou Z, Liu F. Hou Q, et al. Among authors: chen x. Cell Physiol Biochem. 2017;44(6):2256-2268. doi: 10.1159/000486059. Epub 2017 Dec 14. Cell Physiol Biochem. 2017. PMID: 29258088 Free article.

2

[Development of patient-reported outcome scale for myasthenia gravis: a psychometric test].

Chen XL, Liu FB, Guo L, Liu XB. Chen XL, et al. Zhong Xi Yi Jie He Xue Bao. 2010 Feb;8(2):121-5. Zhong Xi Yi Jie He Xue Bao. 2010. PMID: 20141733 Chinese.

3

Evaluation of a scale of patient-reported outcomes for the assessment of myasthenia gravis patients in China.

Liu FB, Chen XL, Guo L, Liu XB. Liu FB, et al. Chin J Integr Med. 2012 Oct;18(10):737-45. doi: 10.1007/s11655-011-0944-3. Epub 2012 Feb 27. Chin J Integr Med. 2012. PMID: 22370869

4

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.

He W, Li Y, Chen X, Lu L, Tang B, Wang Z, Pan Y, Cai S, He Y, Ke Z. He W, et al. Among authors: chen x. J Gastroenterol Hepatol. 2014;29(7):1427-34. doi: 10.1111/jgh.12558. J Gastroenterol Hepatol. 2014. PMID: 24612089

5

[General integral medicine: the strategic direction for complex health interventions].

Hou ZK, Liu FB, Yang YY, Chen XL, Li LJ, Li PW, Liu YP. Hou ZK, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Jun;34(6):645-52. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014. PMID: 25046942 Chinese.

6

[Development and Evaluation of GS-SF for Gastric Stuffiness (Wei PI) Patients Based on Item Response Theory, Computerized Adaptive Testing, and Data Simiuation].

Hou ZK, Liu FB, Chen XL, Li XY, Luo D, Xie D, Luo F, Che XL. Hou ZK, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Jul;35(7):806-15. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26380443 Chinese.

7

Controversies on the values for health instruments of Chinese medicine.

Hou ZK, Chang X, Liu FB, Xie N, Guo N, Chen XL. Hou ZK, et al. Among authors: chen xl. Chin J Integr Med. 2017 Feb;23(2):146-152. doi: 10.1007/s11655-016-2494-1. Epub 2016 Apr 4. Chin J Integr Med. 2017. PMID: 27041333

8

Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Chen X, Hou J, Yuan Y, Huang C, Liu T, Mo C, Li H, Chen B, Xu Q, Hou Z, He W, Liu F. Chen X, et al. Among authors: chen b. BioDrugs. 2016 Jun;30(3):207-17. doi: 10.1007/s40259-016-0173-6. BioDrugs. 2016. PMID: 27120055 Review.

9

Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis.

Chen XL, Chen ZQ, Zhu SL, Liu TW, Wen Y, Su YS, Xi XJ, Hu Y, Lian L, Liu FB. Chen XL, et al. BMC Cancer. 2017 Apr 4;17(1):240. doi: 10.1186/s12885-017-3215-7. BMC Cancer. 2017. PMID: 28376764 Free PMC article.

10

Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.

Huang CY, Zhou QY, Hu Y, Wen Y, Qiu ZW, Liang MG, Mo JL, Xu JH, Sun C, Liu FB, Chen XL. Huang CY, et al. Oncotarget. 2017 Apr 4;8(14):23459-23469. doi: 10.18632/oncotarget.15589. Oncotarget. 2017. PMID: 28423584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117,307 results

Search Page

Filters